Veterinary Molecular Diagnostics Market

Veterinary Molecular Diagnostics Market Outlook (2024 to 2034)

Revenue from the global veterinary molecular diagnostics market size is estimated to reach US$ 211 million in 2024. The market has been analyzed to climb to a value of US$ 463.3 million by the end of 2034, expanding at a CAGR of 7.5% between 2024 and 2034.

• According to a 2020 animal research study conducted by the World Health Organization, zoonotic origins account for approximately 60% to 70% of infectious diseases in humans.

Veterinary molecular diagnostics tests samples from animals. Advancements in the farm animal sector, as well as societal attitudes toward pet animals, have boosted demand for quick and dependable diagnostic techniques. Molecular diagnostics is perfectly suited to this increased demand. Veterinary molecular diagnostics focuses on pathogen detection, identification, and genotyping.

Key Market Growth Drivers

• Growing awareness among veterinarians and pet owners about the advantages of molecular diagnostics in early disease detection and personalized treatment is propelling veterinary molecular diagnostics market growth.
• Supportive regulatory frameworks and guidelines for animal healthcare, as well as initiatives promoting responsible pet ownership and animal welfare, are driving the use of molecular diagnostic tests in veterinary practices.
• Technologically advanced diagnostic products and solutions to detect various diseases in pets and farm animals are benefitting market players.
• Increasing milk and meat consumption, discovery of new diseases among animals, and the transmission of infectious diseases such as anthrax and plague from animals to humans are some of the major factors setting the veterinary molecular diagnostic market trends.
• The global veterinary diagnosis market is also being driven by increased farm animal or pet adoption in developed and developing countries, as well as the rising availability of medical information on the Internet.
• Abundance of readily available information makes pet owners extremely perceptive, increasing the demand for high-quality veterinary care.

Report Attribute	Details
Veterinary Molecular Diagnostics Market Size (2024 E)	US$ 211 Million
Projected Market Value (2034 F)	US$ 436.3 Million
Global Market Growth Rate (2024 to 2034)	7.5% CAGR
Latin America Market Growth Rate (2024 to 2034)	6.9% CAGR
North America Market Growth Rate (2034)	7.3% CAGR
Veterinary Hospitals Segment Value (2024)	US$ 105.2 Million
Livestock Animals Segment Value (2024)	US$ 149.8 Million
Key Companies Profiled	Thermo Fisher Scientific Inc.; IDEXX Laboratories, Inc.; Qiagen N.V.; Neogen Corporation; ID. Vet; bioMérieux SA; INDICAL BIOSCIENCE GmbH; Veterinary Molecular Diagnostics, Inc.

Will Rising Adoption of Pets Create Higher Demand for Veterinary Molecular Diagnostics?

“Increasing Animal Health Expenditure across Regions”

Stringent regulations and consumer demand for safe animal-derived products, such as meat and dairy, are driving the need for rigorous disease monitoring and testing. Continuous advancements in molecular diagnostic technologies are enhancing the accuracy, speed, and range of diagnostic capabilities available to veterinary professionals.

• According to a study published by the University of Calgary in June 2021 to investigate Echinococcus multilocularis infections in domestic dogs to determine their potential role in zoonotic transmission, Echinococcus multilocularis, a parasitic helminth of the northern hemisphere (Alberta, Canada), typically cycles through definitive and intermediate hosts.

In urban areas, domestic dogs can become hosts for this parasite, which could pose a significant risk to humans due to their proximity.

• The Canadian government's article on reportable diseases in terrestrial animals, which was updated in February 2021, listed several diseases that affect animals, including companion animals in the region.

Increase in animal health expenditure is expected to drive the growth of the market, as a sizable proportion of pet owners are expected to use advanced diagnostic modalities for various disease conditions in animals.

• According to the American Pet Products Association's April 2022 estimates, total American pet industry expenditure was set to reach US$ 123.6 billion in 2021, up from US$ 103.6 billion the previous year.

“Rising Adoption of Microarray Technology in Veterinary Diagnostics”

Increasing use of PCR tests such as real-time PCR, assembly PCR, hot-start PCR, methylation-specific PCR (MSP), and nested PCR are some other factors driving growth in molecular diagnostics. Furthermore, RT-PCR technology is low-cost and allows for real-time monitoring of the expression levels of multiple genetic messages. Emergence of biochips and their increasing applications in the identification of infectious diseases is a major driver for microarray technology, which is also contributing to the expansion of the veterinary molecular diagnostics market size.

What Main Challenges are Impacting Market Growth?

“Shortage of Skilled Veterinarians and Limited Understanding of Veterinary Diseases”

Skilled pathologists and veterinarians are in short supply, particularly in developing countries across Latin America (Brazil, Mexico, Argentina), Asia Pacific (India, China), and parts of Africa. This shortage creates a substantial gap between supply and demand in the veterinary profession.

Critical obstacle to global market growth is the inadequate understanding of the epidemiology of endemic veterinary diseases. For instance, the economic impact of insufficient epidemiological knowledge is evident in outbreaks like the Newcastle disease virus (NDV) affecting poultry and other animals. Rapid mutations in various vNDV genotypes exacerbate these knowledge gaps.

Country-wise Insights

North America is expected to hold a significant veterinary molecular diagnostics market share of 41% in 2024, driven by factors such as rising expenditures on animal health insurance, a surge in both clinical and non-clinical visits to veterinary practices, expanding private clinical services for companion animals and equines, a marked increase in pet adoption rates among households, and growth in both companion and livestock animal populations.

How is the Market for Veterinary Molecular Diagnostics Shaping Up in the United States?

“Increased Animal Product Consumption Necessitating Animal Health Monitoring for Food Safety”

Attribute	United States
Market Value (2024E)	US$ 73 Million
Growth Rate (2024 to 2034)	7.2% CAGR
Projected Value (2034F)	US$ 147 Million

Due to increased consumption of meat, milk, and eggs, along with the widespread adoption of pets and farm animals, rigorous diagnosis of animals before consumption is essential in the United States.

• The World Animal Foundation estimates that pneumonia infects 80% of all hog meat consumed globally. According to the CDC, Salmonella zoonotic outbreaks were prevalent in the United States in 2021. Salmonella bacteria infected both chicken and beef.
• The American Society for the Prevention of Cruelty shelters approximately 6.3 million pet animals each year. Cats account for 3.2 million, while dogs make up 3.1 million. Every year, approximately 2.1 million cats and 2 million dogs in the United States are adopted from shelters, increasing pet healthcare spending.

Why is There Growing Interest in Improved Veterinary Diagnostics in Brazil?

“Need for Accurate Pathogen Identification in Veterinary Medicine”

Attribute	Brazil
Market Value (2024E)	US$ 9 Million
Growth Rate (2024 to 2034)	7% CAGR
Projected Value (2034F)	US$ 17 Million

Brazil's diverse geography and climate expose it to a wide array of animal diseases. Molecular diagnostics offer rapid and accurate identification of pathogens, enabling veterinarians to diagnose and treat diseases more effectively. In Brazil, there is an increasing focus among companies and researchers on developing innovative veterinary diagnostics. This emphasis on research and development is one of the key veterinary molecular diagnostics market trends in the country.

Category-wise Insights

The veterinary molecular diagnostics market is categorized into product type, species type, and disease type, and its end users are veterinary hospitals, clinical laboratories, and veterinary research institutes.

PCR kits, INAAT kits, and microarray kits are identified as product types. PCR is set to capture 50% market share in 2024. In terms of species, the livestock segment is poised to hold 70% of the market share in 2024. In addition, Newcastle disease is set to hold a market share of 31.5%, followed by influenza with 26.9% share.

Why is Prioritization of Livestock Animal Diagnostics Important?

“Vulnerability of Livestock to Disease Outbreaks Necessitating Prevention Measures”

Attribute	Livestock Animals
Segment Value (2024E)	US$ 149.8 Million
Growth Rate (2024 to 2034)	7.6% CAGR
Projected Value (2034F)	US$ 311.4 Million

Livestock animals are projected to constitute 71% share of the global market in 2024. Across the globe, people consume animal-derived foods like fish, meat, eggs, poultry, and dairy for balanced nutrition.

Diagnosing animal diseases plays a crucial role in understanding their causes, treatment, and effective management and prevention. The COVID-19 pandemic highlighted the vulnerability of the animal community to outbreaks, which can swiftly escalate to humans. Hence, diagnostics for livestock animals are pivotal in propelling global market expansion.

Why is Demand for PCR Kits Gaining Traction?

“Rapid and Accurate Diagnostic Capabilities of PCR Kits”

Attribute	PCR Kits
Segment Value (2024E)	US$ 107.5 Million
Growth Rate (2024 to 2034)	7.8% CAGR
Projected Value (2034F)	US$ 227.6 Million

PCR kits are poised to account for a substantial 51% market share in 2024 due to their ability to produce precise and reliable results in less time. Polymerase chain reaction (PCR) swiftly identifies bacteria and viruses that grow slowly in cell cultures. PCR provides faster and more precise results compared to traditional methods. Diagnosing animal diseases bridges the gap between disease onset and effective treatment planning, with PCR kits occupying a significant market share.

Competitive Landscape

Key players in the veterinary molecular diagnostics market are investing heavily in R&D to develop advanced molecular diagnostic technologies tailored for veterinary applications. They are entering into partnerships with veterinary clinics, academic institutions, and research organizations to drive innovation and expand their customer base.

• In September 2022, bioMérieux, a leading in vitro diagnostics company, and BrightInsight, a regulated digital health solution company, announced a collaboration to manufacture and supply Clinical Digital Solutions for Diagnostics, which will aid in clinical decision-making in the pet disease area.
• In January 2022, IDEXX Laboratories, Inc. expanded its reference laboratory menu of tests and services, allowing veterinarians to better address the challenges of cancer diagnosis and treatment. The expansion includes a liquid biopsy test that uses next-generation DNA sequencing technology to detect canine cancers.

Fact.MR provides detailed information about the price points of leading providers of veterinary molecular diagnostics positioned across the world, sales growth, production capacity, and technological advancements, in this recently updated market report.

Segmentation of Veterinary Molecular Diagnostics Market Research

• By Product Type :

  • PCR Kits
  • INAAT Kits
  • Microarray Kits
  • DNA Sequencing Kits

• By Species :

  • Livestock Animals
  • Companion Animals

• By Disease :

  • Anaplasma spp.
  • Ehrlichia spp.
  • New Castle Disease
  • Influenza
  • Porcine Reproductive & Respiratory Syndrome

• By End User :

  • Veterinary Hospitals
  • Clinical Laboratories
  • Veterinary Research Institutes

• By Region :

  • North America
  • Western Europe
  • Eastern Europe
  • East Asia
  • South Asia & Pacific
  • Latin America
  • Middle East & Africa